Auto-generated from public data. Not the firm's stated position.
EMBL Ventures appears to focus on early-stage life sciences and health technology companies, with recent portfolio activity concentrated in diagnostics, therapeutics, and specialized medical devices. Based on disclosed data, the firm targets series-a and series-b stage investments with check sizes around €3.0M, suggesting a strategy aligned with translating scientific research into commercial healthcare applications.
Generated 8 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.